Stockscreener 앱 받기
60.22
2.98%
-1.854
전일 마감가:
$62.07
열려 있는:
$61.21
하루 거래량:
10.35M
Relative Volume:
0.61
시가총액:
$89.43B
수익:
$20.62B
순이익/손실:
$3.56B
주가수익비율:
25.25
EPS:
2.3847
순현금흐름:
$3.66B
1주 성능:
-1.26%
1개월 성능:
-12.93%
6개월 성능:
-41.21%
1년 성능:
-40.90%
1일 변동 폭
$60.12
$61.73
1주일 범위
$59.38
$66.88
52주 변동 폭
$59.38
$109.50
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
60.17 | 92.25B | 20.62B | 3.56B | 3.66B | 2.3847 |
ABT
Abbott Laboratories
|
92.69 | 158.35B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
329.04 | 125.43B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
82.92 | 106.97B | 35.48B | 4.64B | 5.41B | 3.582 |
EW
Edwards Lifesciences Corp
|
84.53 | 48.52B | 6.30B | 1.07B | 1.34B | 1.8406 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-30 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-09-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
BSX DEADLINE: ROSEN, LEADING TRIAL COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - GlobeNewswire Inc.
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Boston Scientific (BSX) Unveils Promising Results for Heart Tech - GuruFocus
One Boston Scientific heart device beat drug therapy in new trial data - Stock Titan
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Boston Scientific Corp. Opens with 4.84% Gain, Outperforming S&P 500's 1.05% Increase - Markets Mojo
BSX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Calamos Wealth Management LLC Cuts Stake in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Calamos Advisors LLC - MarketBeat
Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus
BSX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionBSX - TMX Newsfile
A Look at Boston Scientific Corp (BSX) After 5.5% Decline -- GF Value $104.55 vs Price $62.07 - GuruFocus
Boston Scientific Corp (BSX) Stock Price, Trades & News - GuruFocus
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific Corp Stock (BSX) Closed Down by 5.56% on Apr 24: Drivers Behind the Movement - TradingKey
Boston Scientific put volume heavy and directionally bearish - TipRanks
5 Early Q1 Earnings Winners Beating ExpectationsBoston Scientific (NYSE:BSX), GE Vernova (NYSE:GEV) - Benzinga
GE Vernova, Boston Scientific, Intuitive Surgical and other big stocks moving higher on Wednesday - MSN
Med tech company Boston Scientific readies for new Austin offices - MSN
BSX DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionBSX - TMX Newsfile
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Penumbra (PEN) urges shareholders to approve Boston Scientific merger May 6 - Stock Titan
Boston Scientific Corp. stock underperforms Monday when compared to competitors - MSN
Boston Scientific Analysts Slash Their Forecasts After Q1 Earnings - Benzinga
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Alleged Concealment of Electrophysiology Demand Weaknesses: SueWallSt – Company AnnouncementFT. - Financial Times
Teacher Retirement System of Texas Decreases Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation (NYSE:BSX) Q1 2026 Earnings Call Transcript - Insider Monkey
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces a - GlobeNewswire
North Point Portfolio Managers Corp OH Buys New Shares in Boston Scientific Corporation $BSX - MarketBeat
Catheters Market Report 2025-2030, Profiles and Strategy - GlobeNewswire
Rothschild & Co Redburn Adjusts PT on Boston Scientific to $106 From $110, Maintains Buy Rating - marketscreener.com
Boston Scientific reports steady Q1 2026 performance yet tempers FY26 outlook - Medical Device Network
Truist cuts Boston Scientific stock price target on growth outlook - Investing.com
Boston Scientific beats Q1 expectations - medwatch.com
Boston Scientific Corp (BSX) Q1 2026 Earnings Call Highlights: S - GuruFocus
Is It Time To Reassess Boston Scientific (BSX) After Its Recent Share Price Slide - Yahoo Finance
Boston Scientific Faces Headwinds in 2026 That Could Mute Results, but Moat Remains Intact - Morningstar
BSX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - GlobeNewswire Inc.
Boston Scientific net sales up 11.6% to USD 5.203B in Q1 2026 - Medical Buyer
Boston Scientific Trial Wins And Approvals Contrast With Recent Share Weakness - simplywall.st
Boston Scientific Balances Strong Q1 With Softer Outlook - TipRanks
A Look at Boston Scientific Corp (BSX) After 9.0% Gain -- GF Val - GuruFocus
Canaccord cuts Boston Scientific stock price target on guidance reduction By Investing.com - Investing.com South Africa
Canaccord cuts Boston Scientific stock price target on guidance reduction - Investing.com
Stock Market Today, April 22: Boston Scientific Jumps After Q1 Earnings Beat Resets Growth Expectations - The Motley Fool
BSX Maintains Rating by Jefferies -- Price Target Lowered to $10 - GuruFocus
Boston Scientific: Sustained Outperformance and Solid Growth Support Buy Rating Despite Trimmed Target - TipRanks
Penumbra vote May 7 as Boston Scientific (NYSE: PEN) aims H2 2026 close - Stock Titan
RBC Capital cuts Boston Scientific stock price target on guidance reduction - Investing.com
Boston Scientific slashes guidance; why shares rallied - MSN
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
0.51%
자본화:
|
볼륨(24시간):